DEBORAH ABU-ALRUB: Open Payments
NPI 1306162888 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 15 payments from 9 companies in 2025. Trend: 2023 $256 · 2024 $346 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| SpringWorks Therapeutics, Inc. | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| Janssen Biotech, Inc. | 1 | $29 |
| Janssen Scientific Affairs, LLC | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Abbott Laboratories | 1 | $19 |
| ARRAY BIOPHARMA INC | 1 | $18 |
Products named: CAPLYTA, OGSIVEO, KEYTRUDA, KISQALI, TECVAYLI, RYBREVANT, REXULTI, ALINIQ.
Industry payments across AL — which companies pay providers there.
